Document is current
Any future updates will be listed below
-
Authors
Arizmendi, Cara https://orcid.org/0000-0001-5608-7385
Zhu, Yanyan
Khan, Maryam
Gable, Jonathon
Reeve, Bryce B.
King-Kallimanis, Bellinda
Bell, Jill
-
Funding
Funding for this research was provided by:
AstraZeneca United States (AstraZeneca United States)
- License Information
-
More Information
Article History
Accepted: 12 July 2024
First Online: 24 July 2024
Declarations
:
: The study was conducted in accordance with the ethical principles that originated in the Declaration of Helsinki and with local Research Ethics Board approval at each participating center.
: Informed consent was obtained from all individual participants included in the study.
: This manuscript contains no individual person’s data in any form (including any individual details, images or videos).
: CA has research funding from AstraZeneca. CA, YZ, MK, JG, and JB are employees at AstraZeneca. Bellinda King-Kallimanis reports a relationship with AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Jazz Pharma, Genentech, Eli Lilly, Janssen, Takeda, Dachii Sankyo, Blueprint Medicines, Janssen, Amgen, Seagen, and Merck that includes funding grants outside of this work. She also reports a relationship with Eli Lilly, Bristol Myers Squib, IQVIA, Gilead, Shiongi, and Abbvie that includes consulting or advisory outside of this work. All other authors have no disclosures.
